Dental Biomaterials Market Size, Key Companies, Company Market Share, Patient Volume, Treatment Adoption Rates, Pricing Analysis, Regulatory Landscape, Competitive Positioning, and Demand Forecast

Revenue, 2026

USD 10.95 billion

Forecast Year, 2035

USD 19.55 billion

CAGR, 2026 - 2035

6.66%

Report Coverage

Global

What is the Dental Biomaterials Market Size?

The global dental biomaterials market size was estimated at USD 10.26 billion in 2025 and is predicted to increase from USD 10.95 billion in 2026 to approximately USD 19.55 billion by 2035, expanding at a CAGR of 6.66% from 2026 to 2035.

Dental Biomaterials Market Key Takeaway

• North America dominated the global market with the largest market share of 38% in 2025.
• By application, the orthodontics segment contributed the highest market share of 43.6% in 2025.
• By end use, the dental laboratories segment captured the biggest market share in 2025.
• By type, the ceramic biomaterials segment generated a major market share of 37.8% in 2025.

Growth Factors

The factors such as growing geriatric population, surge in number of dental implants, and rising dental disorders are driving the demand for dental biomaterials in the global market. One of the main concerns among people is regarding tooth decay and dental caries. Dental caries afflicted 3.58 billion people worldwide in 2016, as per the World Health Organization (WHO). As a result, the market for dental biomaterials is expanding at rapid pace over the forecast period.

Another prominent factor boosting the expansion of global dental biomaterials market is growing trend of dental tourism. Citizens in the U.S. spent more than $5 billion on dental tourism in 2019. Not only the U.S., but also the other developing nations such as Mexico, Spain, and Indonesia are spending large amount on dental tourism. In addition, India has emerged as top most destination for dental tourism in Asia-Pacific region. Thus, the global dental biomaterials market is expected to grow in coming years.

As per the research study released in the Journal of the Korean Association of Oral and Maxillofacial Surgeons, roughly around 69% of adult population in the U.S. aged 35 to 44 years lost one of the permanent teeth in 2014 owing to an accident, unsuccessful root canal, or gum disorders. Furthermore, the research study estimated that between 100,000 and 300,000 dental implants are implanted annually in the nation. This statistic shows the importance of dental implants. This is directly driving the growth and development of global dental biomaterials market.

In addition, the market for dental biomaterials is also growing due to rising favorable government regulations in favor of dental industry. Furthermore, the growing investments by government as well as major market players are supporting to the growth of global dental biomaterials market.

Market Scope

Segments Insights

Type Insights

The metallic biomaterials segment dominated the dental biomaterials market in 2025. The ceramic dental biomaterials segment is growing due to the rising trend of dental implants and surgeries. The usage of implants has increased considerably in recent years, owing to the growing geriatric populations in developed nations and patients' desire to retain their engagement and standard of living. As a result, there has been a steady increase in the usage for high quality of implantable biomaterials that can solve specific dental issues.

The composite biomaterials segment is expected to witness strong growth from 2025 to 2034. Composite dental biomaterials are manmade materials made up of two or more elements that have vastly different physical and mechanical properties. The specific qualities of the constituent parts as well as their respective volume fractions and configurations in the material system, determine the composite materials' distinguishing properties.

Application Insights

The orthodontics segment accounted largest revenue share in 2025. The demand for dental biomaterials in orthodontics is growing due to the surge in number of dental disorders and tooth decays. In addition, rising disposable income as well as rising medical tourism trend is driving the growth of segment all around the globe. The market for dental biomaterials for orthodontics is also growing due to rising trend of dental implants.

The implantology segment is fastest growing segment of the dental biomaterials market in 2024. Implantology is a discipline of dentistry concerned with the permanent placement of prosthetic teeth in the jaw. The wide range of biomaterials is used in dental implants or implantology. In addition, the growing demand for cosmetic dentistry is also driving the demand for dental biomaterials for implantology in the global market.

End Use Insights

The dental laboratories segment dominated the dental biomaterials market in 38% in 2025. The factors such as growing disorders and infections regarding teeth, growing consumer awareness regarding oral hygiene and health, and growing demand for dental implants and surgeries are driving the growth of dental biomaterials for dental laboratories. In addition, the growth of global dental biomaterials market is also attributed due to growing research and development activities all around the globe.

The dental hospitals and clinics segment is expected to grow at a fastest CAGR from 2025 to 2034. The dental biomaterials are used in dental hospitals and clinics on a large scale. The growing consumer preference for dental implants and growing consumer awareness for health and well being is driving demand for dental biomaterials in dental hospitals and clinics. Thus, the global dental biomaterials market is expected to expand due to this in near future.

Regional Insights

U.S. Dental Biomaterials Market Size and Growth 2026 to 2035

The U.S. dental biomaterials market size was estimated at USD 2.75 billion in 2025 and is predicted to be worth around USD 5.33 billion by 2035, at a CAGR of 6.84% from 2026 to 2035.

North America dominated the dental biomaterials market in 2025. One of the key factors driving the growth of dental biomaterials market in North America region is growing dental disorders. According to the American Dental Association 2020, over 5 million Americans aged 65 to 74 have lost all of their teeth, including approximately 3 million edentulous. On the other side, tooth loss is largely concern for the elderly. This is because 91% of persons aged 20 to 64 have dental caries with 27% of them staying undiagnosed. Other factors driving the regional market growth are growing geriatric population and government initiatives.

What Is Driving the Growth of the Dental Biomaterials Market in Asia Pacific?

Asia-Pacific, on the other hand, is expected to develop at the fastest rate during the forecast period. China and India dominate the dental biomaterials market in Asia-Pacific region. The market for dental biomaterials is growing in Asia-Pacific region due to rising prevalence of tooth and oral diseases. According to 2018 Global Burden of Disease report, the Asia-Pacific region has a significant burden of oral disorders. Furthermore, the growing trend of medical tourism is also boosting the growth of dental biomaterials market in Asia-Pacific region.

Company Profiles

3M

• HQ: Minnesota, United States
• Founded: 1902
• Ownership: Public (NYSE: MMM)
• Business Overview: 3M is a global science and manufacturing company that creates consumer goods, safety gear, and materials for large industries.
• Products: The company offers a wide range of dental biomaterials for multiple applications, catering to direct restoratives & composites, cements & adhesives, and impression & provisional materials. 3M Filtek Z350 XT, 3M RelyX U200 Automix, and Imprint 4 VPS are some common examples.
• Revenue: Net sales of the second quarter of 2026 were $6.5 billion, representing a year-on-year increase of 2.4%.
• Recent Development: 3M announced plans to shift its capital spending within its operating budget to fund upgrades for R&D facilities, focusing on new product development.
• Key Strategies: Major strategies of 3M include: actively managing a business portfolio to drive growth faster than the markets and economies it serves; accelerating digital capabilities and expanding the use of data analytics; and advancing sustainability commitments to reduce greenhouse gas emissions.

Straumann Group

• HQ: Basel, Switzerland
• Founded: 1954
• Ownership: Public (SIX Swiss Exchange: STMN)
• Business Overview: Straumann Group specializes in manufacturing dental implants and related technologies, offering the most innovative and customer-centric oral care solutions in the world to forward-thinking dental professionals and customers.
• Products: Straumann offers a unique portfolio of dental implant materials, such as Roxolid. Other products include Cerabone (bone graft), Jason membrane, and Collprotect membrane, Mucoderm (soft tissue graft), and Edmogain (for periodontal regeneration).
• Revenue: The company reported total revenue of CHF 2.6 billion in FY2025, serving 7.3 million patients. The revenue represents an organic revenue growth of 8.9%.
• Recent Development: In October 2025, Straumann Group collaborated with Smartee-Denti Technology to encompass the joint development of the next-generation orthodontics platform and co-innovation in clear aligner technologies.
• Key Strategies: Straumann Group commits to being the premium partner of choice in tooth replacement and esthetic dentistry, offering education, innovation, quality, support, expertise, clinically proven long-term success, and peace of mind.

Dentsply Sirona

• HQ: North Carolina, United States
• Founded: 2016
• Ownership: Public (NASDAQ: XRAY)
• Business Overview: Dentsply Sirona is an American dental equipment and dental consumables manufacturer that provides collaborative, patient-centered care with integrated software and hardware solutions.
• Products: Dentsply Sirona offers high-performance materials, such as Cercon xt ML, Cercon ht, Cercon ht ML, CEREC Zirconia+, inCoris ZI, Celtra Duo, and CEREC Tessera.
• Revenue: Net sales in the fourth quarter of 2025 were $961 million, compared to $904 million during the same period in 2024. Of these, essential dental solutions accounted for net sales of $372 million.
• Recent Development: In February 2026, Dentsply Sirona and Dreve announced progress on the evaluation of Primeprint Direct Aligner resin that has received FDA clearance.
• Key Strategies: The company focuses on connected dentistry, operational efficiency, and commercial expansion. It aims to reach net-zero carbon emissions by 2050.

Geistlich Pharma AG

• HQ: Wolusen, Switzerland
• Founded: 1851
• Ownership: Private
• Business Overview: Geistlich Pharma AG is a global leader dedicated to advancing regenerative medicine. It offers a diverse range of products that are used in areas such as dentistry, sports medicine, cartilage, and wound healing.
• Products: The company offers bone substitutes like Geistlich Bio-Oss, membranes like Geistlich Bio-Gide, and matrices like Geistlich Fibro-Gide.
• Key Strategies: By the end of 2026, the company's regeneration expert aims to launch 20 new products in more than 40 countries.

Zimmer Biomet Holdings AG

• HQ: Indiana, United States
• Founded: 1927
• Ownership: Public (NYSE: ZBH)
• Business Overview: Zimmer Biomet is a global leader in medical technology that invests in best-in-class implants, as well as digital technology and infrastructure. It advances the quality of patient care and personalizes the care journey.
• Products: The company offers a wide range of autologous therapies and bone graft solutions, including BioCUE Blood and Bone Marrow Aspirate (bBMA) Concentration System and Plasmax Plasma Concentration System.
  Revenue: FY 2025 fourth quarter net sales of Zimmer Biomet were $2.24 billion, while full-year FY 2025 net sales were $8.23 billion.
• Geographic Presence: Zimmer's regional headquarters are located in Switzerland and Singapore. Its manufacturing facilities include Ohio, New Jersey, Puerto Rico, Ireland, Switzerland, and China.
• Key Strategies: Zimmer Biomet focuses on increasing the strategic value of data and connected care, improving execution and margins, and expanding internationally with a focused approach.

Competitive Landscape

The dental biomaterials market is semi-consolidated, driven by the presence of a small group of multinational giants, distributors, testing firms, regulatory bodies, and dental laboratories. Key players like 3M, Dentsply Sirona, and Envista Holdings hold the majority market share, while specialized regional players and innovative material startups like Cementic, Mesosil, and Invicare contribute significantly to market growth.

The market faces formidable challenges, including stringent regulatory policies, funding uncertainties, and gaps in clinical evaluation frameworks. Despite these challenges, the market's future is promising, driven by growing research activities, advances in nanotechnology, and 3D printing technology. Current advancements aim to incorporate suture, which can accelerate wound healing, and electronic threads containing drug-infused polymers.

Dental Biomaterials Market Companies

• 3M Company
• Bego Medical GmbH
• Carpenter Technology Corporation
• Danaher Corporation
• Datum Dental Ltd.
• GC Corporation
• Henry Schein Inc.
• IvoclarVivadent AG
• Keystone Dental Inc.
• Medtronic PLC

Recent Developments

• In 2018, The Straumann Group paid an unspecified price for a 30% investment in Botiss Medical AG, a biomaterials collaborator. Straumann will be able to increase its dental biomaterials portfolio as a result of this strategy.
• MTApexbioceramic root canal sealer, a new endodontic solution from Ultradent Products Inc. was launched in February 2022. MTApex is a bioceramic sealer that may be utilized with any endodontic obturation technique.
• Carpenter Technology Corporation declared the expansion of its Alabama Campus Emerging Technology in 2018.
• Botiss Biomaterials GmbH announced the development of the next generation of dental biomaterials in August 2021. The product is the first dental magnesium biomaterial to be approved by the European Commission. The NOVAMag regeneration system offers dentists a mechanically strong yet totally biodegradable biomaterial that may be replaced with natural bone over time.

Segments Covered in the Report

By Type

• Metallic Biomaterials
• Titanium
• Stainless Steel
• Chromium Alloys
• Other Metallic
• Ceramic Biomaterials
• Polymeric Biomaterials
• Metal-Ceramic Biomaterials
• Natural Biomaterials
• Composites Biomaterials

By Application

• Implantology
• Orthodontics
• Prosthodontics
• Others

By End Use

• Dental Hospitals and Clinics
• Dental Laboratories
• Dental Academics and Research Institutes
• Dental Product Manufacturers

By Bone Graft Material Type

• Allograft
• Xenograft
• Synthetic

By Geography

• North America
• U.S.
• Canada
• Europe
• U.K.
• Germany
• France
• Asia-Pacific
• China
• India
• Japan
• South Korea
• Malaysia
• Philippines
• Latin America
• Brazil
• Rest of Latin America
• Middle East & Africa (MEA)
• GCC
• North Africa
• South Africa
• Rest of the Middle East & Africa